Mepha Ltd.   Report issue

For profit Phase 1 Phase 4
Founded: Basel Switzerland (1949)
Status: Acquired by Cephalon (2010) → now Teva (2011)

Organization Overview

First Clinical Trial
2005
NCT00243737
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Mepha Parma AG, Switzerland